Combined, these results indicate that the severity of sepsis, as deduced from the levels of IL-6, and the time of initiation as well as the maintenance treatment of anti-cytokine strategies will play a pivotal role in the therapeutic outcome. The gene discussed is IL6; the disease is Sepsis.